sglt2 vs glp 1 Renal outcomes of inhibitors and GLP1 agonists in clinical practice Summary of cardiovascular outcome trials
Description
74 The relative influences of other factors on discontinuation are unclear, including changes in insurance coverage, high out-of-pocket costs, medication shortages, 75 or false cessation due to switching to compounded (pharmacy prepared) GLP-1s
Out-of-pocket cost varies by plan, formulary, prior authorization, and the indication on the prescription
GLP-1 helps reduce the levels of glucagon released into your blood
Maintain systemic anti-inflammation: Long-acting agents like semaglutide and tirzepatide sustain anti-inflammatory effects that may deprive malignant cells of supportive inflammatory signals
